Elizabeth (Lisa) Samelson is faculty for Harvard Catalyst’s Postgraduate Education and has been an advisor for the Grant Review and Support Program (GRASP) since 2017. She is an associate scientist at the Institute for Aging Research at Hebrew SeniorLife and assistant professor at Harvard Medical School. Samelson is principal investigator of the Framingham Hyperkyphosis Study, which is funded by the National Institutes of Health, and has conducted numerous investigations in collaboration with the Framingham Study to identify risk factors for declines in musculoskeletal health with aging. She additionally directs the Advanced Aging Research Training Seminar (AARTSS) in the Harvard Translational Research in Aging Training Program, mentoring trainees and early-stage investigators in methods of aging research. Her major areas of expertise include the epidemiology of osteoporosis and related fractures, the links between bone and vascular health, and spinal degeneration. Samelson received a PhD in epidemiology from Columbia University and completed a postdoctoral fellowship in musculoskeletal epidemiology at Boston University School of Medicine.
